정상 치은 조직에서 배양된 각화세포에서 Cyclosporine A에 의한 MMP-1, TIMP-1, TGF-β1의 발현에 관한 연구
The mRNA expression of MMP-1, TIMP-1, TGF-β1 in gingival keratocytes from gingival hyperplasia induced by cyclosporine A
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Cyclosporine A (CsA) is a versatile immunosuppresive agent used to prevent graft rejection syndrome and treat autoimmune disease. One of the major side effects associated with CsA is the abnormal gingival hyperplasia. The purpose of this study was to investigate the relationship between the mRNA expression of the MMP-1, TIMP-1, and TGF-β1 and the concentration of CsA in cultured human gingival keratinocytes. Materials & Methods : Gingival keratocytes were obtained from gingival tissues of 4 healthy donors. The cultured gingival keratocytes were incubated with increasing concentrations of CsA (0-2000 ng/ml) for 24 hours and the expression of MMP-1, TIMP-1, and TGF-β1 were determined by reverse transcription-polymerase chain reaction (RT-PCR). Results : The expressions of MMP-1 and TGF-β1 were not significantly different according to the concentrations of CsA. The expression of TIMP-1 was significantly increased at the CsA concentration of 500 ng/ml. Conclusion : We concluded that the gingival hyperplasia induced by CsA was more related with TIMP-1 than MMP-1 or TGF-β1 on gingival collagen metabolism in patients treated with CsA.
Abstract
Cyclosporine A (CsA) is a versatile immunosuppresive agent used to prevent graft rejection syndrome and treat autoimmune disease. One of the major side effects associated with CsA is the abnormal gingival hyperplasia. The purpose of this study was to investigate the relationship between the mRNA expression of the MMP-1, TIMP-1, and TGF-β1 and the concentration of CsA in cultured human gingival keratinocytes. Materials & Methods : Gingival keratocytes were obtained from gingival tissues of 4 healthy donors. The cultured gingival keratocytes were incubated with increasing concentrations of CsA (0-2000 ng/ml) for 24 hours and the expression of MMP-1, TIMP-1, and TGF-β1 were determined by reverse transcription-polymerase chain reaction (RT-PCR). Results : The expressions of MMP-1 and TGF-β1 were not significantly different according to the concentrations of CsA. The expression of TIMP-1 was significantly increased at the CsA concentration of 500 ng/ml. Conclusion : We concluded that the gingival hyperplasia induced by CsA was more related with TIMP-1 than MMP-1 or TGF-β1 on gingival collagen metabolism in patients treated with CsA.
참고문헌 (36)
- Boltchi FE, "Cyclosporine A-induced gingival overgrowth: a comprehensive review", Quintessence Int, 30, pp.775~783 (1999)
- Kantarci A, "Clinical effects of periodontal therapy on the severity of cyclosporin A-induced gingival hyperplasia", J Periodontol, 70, pp.587~593 (1999)
- Tipton DA, "Altered collagen metabolism in nifedipine-induced gingival overgrowth", J Periodontal Res, 29, pp.401~409 (1994)
- Brown RS, "On the mechanism of drug-induced gingival hyperplasia", J Oral Pathol Med, 20, pp.201~209 (1991)
- Seymour RA, "The pathogenesis of drug induced gingival overgrowth", J Clin Periodontol, 23, pp.165~175 (1996)
- Seymour RA, "Cyclosporin and the gingival tissues", J Clin Periodontol, 19, pp.1~11 (1992)
- David-Neto E, "Impact of cy closporin A pharmacokinetics on the presence on side effects in pediatric renal transplantation", J Am Soc Nephrol, 11, pp.343~349 (2001)
- Starzl TE, "The use of cyclosporin A and prednisone in cadaver kidney transplantation", Surg Gynecol Obstet, 151, pp.17~26 (1980)
- Ryffel B, "Toxicological evaluation of cyclosporin A", Arch Toxicol, 53, pp.107~141 (1983)
- Rateitschak-pluss EM, "Initial observation that cyclosporin-A induces gingival enlargement in man", J Clin Periodontol, 10, pp.237~246 (1983)
- Emingil G, "Levels of leukotriene B4 and platelet activating factor in gingival crevicular fluid in renal transplant patients receiving cyclosporin-A", J Perodontol, 71, pp.50~7 (2000)
- Nagase H, "Structure and function of matrix metalloproteinases and TIMPs", Cardiovasc Res, 69, pp.562~573 (2006)
- Maiola MP, "Related Factors influencing phenytoin-induced gingival enlargement", J Clin Periodontol, 27, pp.506~512 (2000)
- Naidoo LC, "Nifedipine-induced gingival hyperplasia : non-surgical managment of a patients", Spec Care Dentist, 19, pp.29~34 (1999)
- Tumini V, "Hyperplastic gingival lesions in pregnancy. I. Epidemiology pathology and clinical aspects", Minerva stomatol, 47, pp.159~167 (1998)
- Weckx LL, "Oral manifestations of leukemia", Ear Nose Thoat J, 69, pp.341~342 (1990)
- Stambaugh RV, "Ascorbic acid deficiency associated with dilantin hyperplasia", J Periodontol, 44, pp.244~247 (1973)
- Turkmen A, "Relationship between gingival hyperplasia and class Ⅱ histocompatibility antigens in renal transplant recipients", Nephron, 84, pp.29~31 (2000)
- Atilla G, "Matrix Metalloproteinases (MMP-8 and -9) and neutrophil elastase in gingival crevicular fluid of cyclosporin-treated patients", J Periodontol, 72, pp.354~360 (2001)
- Varga E, "Medication influencing the development of gingival overgrowth in renal transplant patients", Transplant Proc, 30, pp.2120~2121 (1998)
- Kohnle M, "Conversion to tacrolimus in cyclosporin A treated patients with gum hyperplasia", Transplant Proc, 30, pp.2122~2123 (1998)
- Nash MM, "Efficacy of azithromycin in the treatment of cyclosproine-induced gingival hyperplasia in renal transplant recipients", Transplant Proc, 65, pp.1611~1615 (1998)
- Wirnsberger GH, "Effect of antibiotic treatment with azithromycin on cyclosporin A-induced gingival hyperplasia among renal transplant recipient", Transplant Proc, 30, pp.2117~2119 (1998)
- Citterio F, "Azithromycin treatment of gingival hyperplasia in kidney transrecipients is effective and safe", Transplant Proc, 33, pp.2134~2135 (2001)
- Hyland PL, "The effects of cyclosporin on the collagenolytic activity of gingival fibroblasts", J Periodontol, 74, pp.437~445 (2003)
- Tuter G, "Evaluation of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 levels in gingival fibroblasts of cyclosporin A-treated patients", J Periodontol, 73, pp.1273~1278 (2002)
- 김용재, "Cyclosporine에 의한 치은증식에 관한 실험적 연구", Maxillofacial Plastic Reconstructive Surgery, 27(5), pp.438~445 (2005), 대한악안면성형재건외과학회
- Cotrim P, "Cyclosporin A induces proliferation in human gingival fibroblasts via induction of transforming growth factor-beta1", J Periodontol, 74, pp.1625~1633 (2003)
- Gagliano N, "Effect of cyclosporin A on human gingival fibroblast collagen turnover in relation to the development of gingival overgrowth: an in vitro study", Biomed Pharmacother, 58, pp.231~238 (2004)
- Yoshida T, "Growth factors and proliferation of cultured rat gingival cells in response to cyclosporin A", J Periodontal Res, 40, pp.11~19 (2005)
- Cotrim P, "Martelli-Junior H et al : Expression of matrix metalloproteinases in cyclosporin-treated gingival fibroblast is regulated by transforming growth factor (TGF)-beta1 autocrine stimulation", J Periodontol, 73, pp.1313~1322 (2002)
- 김영면, "Cyclosporine A에 의해 과증식된 치은 조직에서 배양된 섬유아세포의 성장인자 발현에 관한 연구", Maxillofacial Plastic Reconstructive Surgery, 28(5), pp.445~453 (2006), 대한악안면성형재건외과학회
- Pisanty S, "Prolonged systemic administration of cyclosporin A affects gingival epithelium", J Periodontol, 61, pp.138~141 (1990)
- Pisanty S, "The effect of cyclosporin A (CsA) treatment on gingival tissue of patients with Behcet's disease", J Periodontol, 59, pp.599~603 (1988)
- Nurmenniemi PK, "Mast cell subpopulations in gingival overgrowth induced by immunosuppressive and nifedipine medication", J Periodontol, 75, pp.933~938 (2004)
- Esposito C, "Cyclosporine induces different responses in human epithelial, endothelial and fibroblast cell cultures", Kidney Int, 58, pp.123~130 (2000)
